Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
Batt Frederic, El Bousmaqui Mohamed, Fraser Graeme L, Dutheuil Guillaume, Hoveyda Hamid R, Roy Marie-Odile
Year of Publication 25.10.2016
Get full text
Year of Publication 25.10.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS
BATT, FRÉDÉRIC, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME, HOVEYEDA, HAMID
Year of Publication 31.08.2016
Get full text
Year of Publication 31.08.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-(1,2,4)TRIAZOLO(4,3-A)PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS
ROY Marie-Odile, FRASER Graeme, EL BOUSMAQUI Mohamed, BATT Frederic, HOVEYEDA Hamid, DUTHEUIL Guillaume
Year of Publication 31.08.2016
Get full text
Year of Publication 31.08.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS
BATT, FRÉDÉRIC, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME, HOVEYEDA, HAMID
Year of Publication 24.08.2016
Get full text
Year of Publication 24.08.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
Roy, Marie-Odile, Fraser, Graeme, El Bousmaqui, Mohamed, Dutheuil, Guillaume, Hoveyeda, Hamid, Batt, Frédéric
Year of Publication 15.07.2016
Get full text
Year of Publication 15.07.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
BATT, FRÉDÉRIC, HOVEYDA, HAMID, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME
Year of Publication 08.06.2016
Get full text
Year of Publication 08.06.2016
Patent
HIDTIL UKENDTE CHIRALE N-ACYL-5,6,7,(8-SUBSTITUERET)-TETRAHYDRO-[1,2,4]TRIAZOL[4,3-A]PYRAZINER SOM SELEKTIVE NK-3-RECEPTORANTAGONISTER, FARMACEUTISK SAMMENSÆTNING OG FREMGANGSMÅDER TIL ANVENDELSE VED NK-3-RECEPTORMEDIEREDE SYGDOMME
BATT, FRÉDÉRIC, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, FRASER, GRAEME, DUTHEUIL, GUILLAUME, HOVEYEDA, HAMID
Year of Publication 25.04.2016
Get full text
Year of Publication 25.04.2016
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS
BATT, FRÉDÉRIC, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME, HOVEYEDA, HAMID
Year of Publication 06.04.2016
Get full text
Year of Publication 06.04.2016
Patent
Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor mediated disorders and chiral synthesis thereof
DUTHEUIL GUILLAUME, ROY MARIE-ODILE, FRASER GRAEME, EL BOUSMAQUI MOHAMED, BATT FREDERIC, HOVEYDA HAMID
Year of Publication 23.12.2015
Get full text
Year of Publication 23.12.2015
Patent
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS
BATT, FRÉDÉRIC, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME, HOVEYEDA, HAMID
Year of Publication 13.08.2014
Get full text
Year of Publication 13.08.2014
Patent